News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|July 9, 2021

Understanding Treatment Options in Melanoma

Author(s)Kristie L. Kahl

On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
skin cancer

Similar Incidence of Second Primary Tumors After Libtayo or Placebo for CSCC

ByJax DiEugenio
October 18th 2025
melanoma

Postsurgical Opdivo Associated With Long-Term Activity in Melanoma

ByKyle Doherty
October 18th 2025
Image of woman.

Patients With Cancer Urged to Ask Questions, Take Notes and Do Their Research

ByAlex Biese
October 14th 2025
Image of woman.

What Subcutaneous Keytruda Means for Patients With Melanoma

ByAlex Biese
October 12th 2025
Image of skin.

What Newly Diagnosed Patients Need to Know About Stage 2 Melanoma

ByRyan Scott
October 10th 2025
Advertisement
Advertisement

Trending on CURE

1

Trodelvy Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer

2

Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer

3

Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study

4

Trodelvy in Metastatic Triple-Negative Breast Cancer Supported by Phase 3 Trial

5

Ivonescimab Combo Improves Progression-Free Survival in Advanced NSCLC

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.